Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 40:890-895
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlüter, M.
Right arrow Articles by Schofer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlüter, M.
Right arrow Articles by Schofer, J.

CLINICAL STUDY: PERCUTANEOUS CORONARY INTERVENTION

Feasibility and efficacy of balloon-based neuroprotection during carotid artery stenting in a single-center setting

Michael Schlüter, PhD*, Thilo Tübler, MD*, Detlef G. Mathey, MD, FACC* and Joachim Schofer, MD*,*

* Center of Cardiology and Vascular Intervention, Hamburg, Germany

Manuscript received December 27, 2001; revised manuscript received April 25, 2002, accepted May 24, 2002.

* Reprint requests and correspondence: Dr. Joachim Schofer, Center for Cardiology and Vascular Intervention, Othmarscher Kirchenweg 168, 22763 Hamburg, Germany.
schlueter{at}center-for-cardiology.de

OBJECTIVES: We sought to prospectively assess the feasibility and in-hospital efficacy of the PercuSurge GuardWire temporary balloon-occlusive system for neuroprotection during carotid angioplasty and stenting (CAS).

BACKGROUND: Carotid angioplasty and stenting harbors a risk of distal embolization. Cerebral protection devices are currently under clinical investigation.

METHODS: Ninety-six consecutive patients with carotid bifurcation disease underwent a total of 102 CAS procedures with the intention to use the GuardWire for neuroprotection.

RESULTS: GuardWire deployment was achieved in 99 procedures performed in 93 patients (97%). Device failure (n = 3) and severe neurologic responses to balloon occlusion of the targeted carotid artery (n = 2) accounted for five additional procedures that were essentially concluded without neuroprotection, for a total of 94 procedures completed as intended in 88 patients (92% procedural feasibility rate). Carotid angioplasty and stenting was performed successfully in 94 patients (100 procedures). There were no in-hospital deaths; but three patients (3.1%) sustained strokes, and two patients experienced transient ischemic attacks, for a total periprocedural complication rate of 5.2%. One major stroke occurred with the GuardWire in place, whereas two minor strokes were observed in patients in whom the device could not be deployed. Thus, successful neuroprotected CAS without major neurologic events was achieved in 87 patients (91%).

CONCLUSIONS: The GuardWire temporary balloon-occlusive system is feasible as an adjunct to CAS in the majority of patients. It is associated with a 3.1% rate of major periprocedural neurologic complications. Adverse neurologic reactions to balloon occlusion may prohibit effective use of the system in about 2% of patients.

Abbreviations and Acronyms
  CAS
  carotid angioplasty and stenting
  CI
  confidence interval
  ICA
  internal carotid artery
  NIH
  National Institutes of Health
  TIA
  transient ischemic attack




This article has been cited by other articles:


Home page
StrokeHome page
W. Theiss, P. Hermanek, K. Mathias, H. Bruckmann, J. Dembski, F.-J. Hoffmann, R. Kerner, F. Leisch, H. Mudra, K.-L. Schulte, et al.
Predictors of Death and Stroke After Carotid Angioplasty and Stenting: A Subgroup Analysis of the Pro-CAS Data
Stroke, August 1, 2008; 39(8): 2325 - 2330.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W. Theiss, P. Hermanek, K. Mathias, R. Ahmadi, L. Heuser, F.-J. Hoffmann, R. Kerner, F. Leisch, H. Sievert, S. von Sommoggy, et al.
Pro-CAS: A Prospective Registry of Carotid Angioplasty and Stenting
Stroke, September 1, 2004; 35(9): 2134 - 2139.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
B. E. Cil, E. Akpinar, B. Peynircioglu, and S. Cekirge
Utility of Covered Stents for Extracranial Internal Carotid Artery Stenosis
AJNR Am. J. Neuroradiol., August 1, 2004; 25(7): 1168 - 1171.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. Sabeti, M. Schillinger, W. Mlekusch, T. Nachtmann, W. Lang, R. Ahmadi, and E. Minar
Contralateral High-Grade Carotid Artery Stenosis or Occlusion Is Not Associated with Increased Risk for Poor Neurologic Outcome after Elective Carotid Stent Placement
Radiology, January 1, 2004; 230(1): 70 - 76.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Schluter, T. Tubler, J. C. Steffens, D. G. Mathey, and J. Schofer
Focal ischemia of the brain after neuroprotected carotid artery stenting
J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1007 - 1013.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F. Liistro and C. Di Mario
Carotid artery stenting
Heart, August 1, 2003; 89(8): 944 - 948.
[Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
S. Taylor, F. Alcocer, and W. D. Jordan Jr
Controversies in Carotid Stenting
Vascular and Endovascular Surgery, March 1, 2003; 37(2): 79 - 87.
[Abstract] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement